DAVID S MAZZA MD
NPI 1750302410
Allergy & Immunology - Allergy in New York, NY

Active since July 21, 2006PECOS Enrolled
91.25/100
CMS Quality Rating
7 LEXINGTON AVENUE, SUITE 3, NEW YORK, NY 10010(212) 677-7170(212) 677-8501 Get Directions Write a Review

NPPES record last updated: April 26, 2021. Verified against the NPPES registry weekly; last sync: August 16, 2026.

About David S Mazza Md NPPES

Official registry information on file with the National Plan and Provider Enumeration System.

DAVID S MAZZA MD (NPI 1750302410) is an individual allergy provider in New York, New York, licensed in New York (136247) and active in the NPI registry since July 2006. He is enrolled in Medicare PECOS.

NPPES Registry Identity

NPI1750302410
Entity TypeIndividualMale
Primary Taxonomy207KA0200X
Provider Legal NameDAVID S MAZZACredential: MD
Location Address7 LEXINGTON AVENUE, SUITE 3New York, NY 10010-5530
Mailing Address316 E 30th St Fl 2New York, NY 10016-8366 · (212) 614-0089 · Fax (212) 253-9631
Fax(212) 677-8501
Sole ProprietorNo
Enumeration DateJuly 21, 2006
Last NPPES UpdateApril 26, 2021
NPPES CertifiedApril 26, 2021
NPI 1750302410 is a valid, active identifier and passes the ISO check-digit test.

Specialties & Licenses

Primary SpecialtyAllergy & Immunology · AllergyAllopathic & Osteopathic Physicians
Taxonomy Code207KA0200X
License Licensed in NY · 136247
Definition
A physician who specializes in the diagnosis, treatment, and management of allergies. Source: National Uniform Claim Committee
7 LEXINGTON AVENUE, New York, NY 10010

Other Identifiers 3

Other6710725004Cigna
Other80A881Blue Cross Pos Ppo & Seni
Other010136247NY01Anthem Health

Medicare Participation & PECOS CMS

Medicare enrollment, assignment, and ordering and referring status from the CMS PECOS system.

Medicare Enrollment Status

Enrolled in Medicare (PECOS)

David S Mazza Md is registered in the CMS Provider Enrollment, Chain and Ownership System (PECOS).

Eligible to Order & Refer Part B Labs & Imaging Durable Medical Equipment Home Health Agency Power Mobility DevicesPer the CMS Ordering and Referring file. Eligibility means Medicare pays claims that this provider orders or refers for these categories.

Medicare Quality Performance CMS QPP · MIPS

Performance in the CMS Quality Payment Program: the MIPS final score across four weighted categories, and the individual quality measures reported to Medicare.

91.25/100
MIPS Final ScoreMerit-based Incentive Payment System · CMS Quality Payment Program
Scored through an Alternative Payment Model
Quality74.92
Promoting Interoperability91.67
Improvement Activities40

Reported Quality Measures

Breast Cancer Screening
Percentage of women 50-74 years of age who had a mammogram to screen for breast cancer
32%123 patients2/55-star benchmark: 92%
Cervical Cancer Screening
Percentage of women 21-64 years of age who were screened for cervical cancer using either of the following criteria: - Women age 21-64 who had cervical cytology performed every 3 years - Women age 30-64 who had cervical cytology/human papillomavirus (HPV)…
29%311 patients
Colorectal Cancer Screening
Percentage of adults 50-75 years of age who had appropriate screening for colorectal cancer
33%214 patients2/55-star benchmark: 85%
e-Prescribing
At least one permissible prescription written by the MIPS eligible clinician is queried for a drug formulary and transmitted electronically using certified EHR technology.
99%2,260 patients5/55-star benchmark: 99%
Medication Reconciliation
The MIPS eligible clinician performs medication reconciliation for at least one transition of care in which the patient is transitioned into the care of the MIPS eligible clinician.
5%558 patients1/55-star benchmark: 100%
Patient-Specific Education
The MIPS eligible clinician must use clinically relevant information from CEHRT to identify patient-specific educational resources and provide access to those materials to at least one unique patient seen by the MIPS eligible clinician.
19%934 patients1/55-star benchmark: 97%
Pneumococcal Vaccination Status for Older Adults
Percentage of patients 65 years of age and older who have ever received a pneumococcal vaccine
22%98 patients1/55-star benchmark: 90%
Preventive Care and Screening: Influenza Immunization
Percentage of patients aged 6 months and older seen for a visit between October 1 and March 31 who received an influenza immunization OR who reported previous receipt of an influenza immunization
6%323 patients1/55-star benchmark: 88%
Preventive Care and Screening: Tobacco Use: Screening and Cessation Intervention
Percentage of patients aged 18 years and older who were screened for tobacco use one or more times within 24 months AND who received tobacco cessation intervention if identified as a tobacco user
Patients tobacco: 71% · 243 patients
73%243 patients
Provide Patient Access
At least one patient seen by the MIPS eligible clinician during the performance period is provided timely access to view online, download, and transmit to a third party their health information subject to the MIPS eligible clinician's discretion to withhold…
35%934 patients2/55-star benchmark: 100%
Secure Messaging
For at least one unique patient seen by the MIPS eligible clinician during the performance period, a secure message was sent using the electronic messaging function of CEHRT to the patient (or the patient-authorized representative), or in response to a secure…
35%934 patients2/55-star benchmark: 89%
Use of High-Risk Medications in the Elderly
Percentage of patients 65 years of age and older who were ordered high-risk medications. Two rates are submitted. 1) Percentage of patients who were ordered at least one high-risk medication.
Lower rates are better for this measure.
Patients 2+: 3% · 98 patients
3%98 patients4/55-star benchmark: 100%
View, Download, or Transmit (VDT)
At least one patient seen by the MIPS eligible clinician during the performance period (or patient-authorized representative) views, downloads or transmits their health information to a third party during the performance period.
11%934 patients
Providers report different measures because they deliver different services; reporting more or less information is not a reflection of quality. Star ratings appear only where CMS assigned them.

Frequently Asked Questions NPPES & CMS

Common questions about this NPI record, answered from the official NPPES registry and CMS datasets shown on this page.

What is David Mazza's NPI number?

The NPI number for David Mazza is 1750302410. It was assigned to this individual provider in the NPPES registry on July 21, 2006.

Where is David Mazza located?

David Mazza practices at 7 Lexington Avenue Suite 3, New York, NY 10010. The listed phone number is (212) 677-7170.

What is David Mazza's specialty?

The primary specialty registered for this NPI is Allergy & Immunology, specializing in Allergy, with taxonomy code 207KA0200X.

Is David Mazza enrolled in Medicare?

Yes. David Mazza is registered in the Medicare PECOS enrollment system.

When was this NPI record last updated?

The NPPES record for David Mazza was last updated on April 26, 2021. NPI Profile syncs weekly with the NPPES registry data releases published by CMS. This NPI record was last updated 5 years ago. If this record has changed at CMS more recently, you can request an on-demand re-check against the live CMS registry, directly from this page.